What is Medispec?
Medispec is a distinguished global manufacturer specializing in non-invasive medical devices, with a core focus on shockwave therapy. For over three decades, the company has been at the forefront of developing innovative, high-quality medical device designs tailored to meet the evolving needs of healthcare professionals. Their extensive product portfolio spans multiple medical disciplines, including urology, orthopedics, sexual health, aesthetics, cardiology, and veterinary care. Medispec's commitment to advancing non-invasive treatment options is evident in their global reach, serving doctors in more than 80 countries. Key offerings include the ED1000 for erectile dysfunction and the LilyCare system for women's health, alongside various imaging solutions, all trusted for their efficacy and non-invasive nature.
How much funding has Medispec raised?
Medispec has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Medispec?
With a history of substantial capital infusion and a recent major strategic investment, Medispec is well-positioned for continued expansion and innovation in the non-invasive medical device market. The company's extensive experience and global presence suggest a trajectory focused on scaling its operations, further developing its specialized shockwave therapy technologies, and potentially exploring new therapeutic areas or geographical markets. This latest backing will likely fuel research and development efforts, enhance manufacturing capabilities, and strengthen its distribution networks worldwide, reinforcing its role as a leader in providing advanced, non-invasive healthcare solutions.
See full Medispec company page
